Tempus, Eric Lefkofsky, and the Rise of Data-Enabled Precision Medicine

Eric Paul Lefkofsky is a serial entrepreneur based in the United States. Eric Paul Lefkofsky is also the CEO and Co-Founder of Tempus. Eric Paul Lefkofsky has also co-founded a wide range of companies like Inner Workings, Echo Global Logistics, Groupon, and Media Ocean. Eric Paul Lefkofsky is also the founder of the Chicago-based capital venture company by the name Light Bank.

Eric Paul Lefkofsky was born in Michigan and grew up in Southfield. His father’s name is Bill. He was a teacher and a structural engineer from a Jewish origin. Steven is his brother who is an attorney practicing in Michigan. In 1987, Eric Paul Lefkofsky graduated from Southfield High School. He moved forward to attend the Michigan University to study Law. He graduated with the highest honors from the Michigan Law School and learn more about Eric.

Eric Paul Lefkofsky commenced his career while he was still at the University of Michigan. After graduating from the Michigan University Law School, Eric Paul Lefkofsky and his friend Brad Keywell commenced the Brandon Apparel as their first venture from borrowed money. Eric Paul Lefkofsky and his friend created an internet company by the name Starbelly that specialized in the issuance of promotion services and products. This was the beginning of his entrepreneurial skills.

With more than 40 percent of all adults in the United States facing a cancer diagnosis, everyone knows that most people need to battle this disease at some point in their lives. According to the United States Cancer Institute, over 14 million people live with cancer in the country. We also expect that figure to increase as the world becomes a worse place with the rise of immune-response teams. Thanks to companies like Tempus that are looking to a nation that takes cancer to be a severe disease and read full article.

Eric Paul Lefkofsky is the Co-Founder and Chairman of Tempus. Tempus is one of the leading data-enabled precision medicines in the country. Since much as been made from the development of increased necessities, it appears that the healthcare industry is slow in adopting the use of technology. It was until when Eric Paul Lefkofsky’s wife was diagnosed with cancer when he knew the disease is not far from anyone and Eric’s lacrosse camp.

More Visit: http://chicagoinno.streetwise.co/2016/07/22/eric-lefkofskys-next-move-curing-cancer-at-tempus/

Eric Lefkofsky’s Passion Project

Eric Lefkofsky is known in the tech world as the co-founder and developer of giants like Groupon, Mediaocean, and InnerWorkings. Curating and cultivating companies of that caliber grew Lefkofsky’s wealth to a staggering $1.7 billion according to Forbes. Having laid the foundation for his life, he exited the world of startup companies and set out to never have to be involved in that labor intensive process again and learn more about Eric.

That fact would have remained true, but then Lefkofsky’s wife Liz was diagnosed with breast cancer. When they were thrown into the world of a cancer patient and the loved one of a cancer patient, they quickly realized all the many gaps in the ability of oncologists to provide a comprehensive list of options for treatment. Not one to be a passive participant in an important process like this, Lefkofsky developed Tempus.

Tempus’ overall goal is to provide usable data to health care providers. In order to achieve this, the company had to establish connections with some of the nations leading medical facilities. Physicians at the Mayo Clinic, Northwestern University, the University of Chicago, and the University of Michigan send their patients that are diagnosed with cancer to Tempus. From there, each person is sequenced in Tempus’ labs. At this point the patient’s individual molecular and clinical information are input into the database. The physician that originally sent the patient to Tempus is then given access to the system and is able to see what mutations the patient may have. It also allows them to see treatment histories for the patient’s mutation type and what approaches worked best on a retroactive basis. At its core, Tempus is still a data company, but the data is then translated to be a productive tool for the medical community.

The model of Tempus is the first of its kind and has the potential to create life altering results. The impact of Tempus has yet to be fully realized as it is still in its infancy, but when those results make themselves known, they will be astounding for the medical community and Eric’s lacrosse camp.

More visit: http://investor.groupon.com/directors.cfm